Cardiovascular Research

Fatty acid and phospholipid selectivity of different phospholipase A2 enzymes studied by using a mammalian membrane as substrate

Authors: E Diez|||F H Chilton|||G Stroup|||R J Mayer|||J D Winkler|||A N Fonteh

Affiliations: + Expand

Abstract

Previous studies using phospholipid mixed vesicles have demonstrated that several types of phospholipase A2 (PLA2) enzymes exhibit different selectivity for fatty acids at the sn-2 position, for the type of chemical bond at the sn-1 position or for the phosphobase moiety at the sn-3 position of phospholipids. In the present study, we have utilized natural mammalian membranes from U937 monocytes to determine whether two purified 14 kDa PLA2 isoenzymes (Type I, Type II) and a partially purified 110 kDa PLA2 exhibit substrate selectivity for certain fatty acids or phospholipids. In these studies, arachidonic acid (AA) release from membranes was measured under conditions where the remodelling of AA mediated by CoA-independent transacylase (CoA-IT) activity has been eliminated. In agreement with the mixed-vesicle models, AA was the major unsaturated fatty acid hydrolysed from membranes by the 110 kDa PLA2, suggesting that this PLA2 is selective in releasing AA from natural membranes. By contrast, Type I and Type II PLA2s were less selective in releasing AA from phospholipids and released a variety of unsaturated fatty acids at molar ratios that were proportional to the ratios of these fatty acids in U937 microsomal membranes. Examination of AA release from phospholipid classes indicated that all three enzymes released AA from the major AA-containing phospholipid classes (phosphatidylethanolamine, phosphatidylcholine, and phosphatidylinositol) of U937 membranes. The 110 kDa PLA2 released AA from phospholipid subclasses in ratios that were proportional to the AA content within phospholipid classes and subclasses of U937 membranes. These data suggested that the 110 kDa PLA2 shows no preference either for the sn-1 linkage or for the sn-3 phosphobase moiety of phospholipids. By contrast, Type I and Type II PLA2s preferentially released AA from ethanolamine-containing phospholipids and appeared to prefer the 1-acyl-linked subclass. Taken together, these data indicate that the 110 kDa PLA2 selectively releases AA from U937 membranes, whereas Type I and Type II PLA2 release a variety of unsaturated fatty acids. Furthermore, the 110 kDa PLA2 releases the same molar ratios of AA from all major phospholipid subclasses, whereas Type I and Type II PLA2s show some specificity for phosphatidylethanolamine when these enzymes are incubated with a complex mammalian membrane substrate.

---

Chemical List

Fatty Acids|||Fatty Acids, Unsaturated|||Isoenzymes|||Membrane Lipids|||Phosphatidylcholines|||Phosphatidylethanolamines|||Phosphatidylinositols|||Phospholipids|||Arachidonic Acid|||Phospholipases A|||Phospholipases A2

---

Reference List

J Mol Biol. 1981 Mar 25;147(1):97-123|||Can J Biochem Physiol. 1959 Aug;37(8):911-7|||Biochim Biophys Acta. 1982 Sep 14;712(3):667-76|||J Biol Chem. 1983 Nov 25;258(22):13806-11|||Life Sci. 1985 Feb 11;36(6):579-87|||J Biol Chem. 1985 Jun 25;260(12):7295-303|||J Biol Chem. 1987 Jan 25;262(3):1199-205|||Biochem Biophys Res Commun. 1987 Jun 30;145(3):1126-33|||Br Med Bull. 1987 Apr;43(2):285-96|||J Biol Chem. 1989 Apr 5;264(10):5335-8|||J Biol Chem. 1989 Apr 5;264(10):5768-75|||J Biol Chem. 1990 Apr 5;265(10):5409-13|||Biochim Biophys Acta. 1990 May 1;1044(1):139-46|||J Biol Chem. 1990 Jun 25;265(18):10622-30|||J Biol Chem. 1990 Aug 25;265(24):14654-61|||Methods Enzymol. 1990;187:157-67|||Adv Exp Med Biol. 1990;275:83-101|||Am Rev Respir Dis. 1991 Jan;143(1):188-203|||Science. 1990 Dec 14;250(4987):1560-3|||Biochim Biophys Acta. 1991 Feb 5;1081(3):339-46|||J Biol Chem. 1991 Mar 15;266(8):5268-72|||J Biochem. 1990 Dec;108(6):903-6|||Cell. 1991 Jun 14;65(6):1043-51|||Anal Biochem. 1991 Jan;192(1):173-80|||Science. 1991 Nov 15;254(5034):1007-10|||Eur J Biochem. 1991 Dec 18;202(3):873-80|||Agents Actions. 1991 Sep;34(1-2):103-5|||J Immunol. 1992 Mar 15;148(6):1784-91|||J Biol Chem. 1992 Sep 15;267(26):18342-8|||Biochem Pharmacol. 1992 Nov 3;44(9):1849-58|||J Biol Chem. 1993 Jan 15;268(2):839-44|||J Biol Chem. 1993 Feb 5;268(4):2865-71|||FASEB J. 1993 Feb 1;7(2):339-48|||Biochim Biophys Acta. 1993 May 20;1168(1):37-44|||Biochemistry. 1993 Jun 15;32(23):5949-58